01/03/2023 (Agence Europe) – The European Commission decided on Wednesday 1 March to refer to the Belgian national competition authority the assessment of the proposed acquisition of joint control of Pannoc Chemie NV (Pannoc) by ACE Pharmaceuticals Belgium NV (ACE Belgium) and Febelco CV, both established in Belgium. Pannoc develops, manufactures, packages and sells medicines, medical devices and cosmetics in the form of creams, salves, gels, lotions and solutions. ACE Belgium is a joint venture between Pharmentum NV (Belgium) and ACE Pharma Group BV (the Netherlands). ACE Belgium distributes the medicines of ACE Pharma Group BV, which develops, produces, registers and sells medicines. Febelco is a wholesale distributor of pharmaceutical products. (LC)